Literature DB >> 15661626

Nicotine: from molecular mechanisms to behaviour.

Susan Wonnacott1, Nimish Sidhpura, David J K Balfour.   

Abstract

The addictive potential of nicotine is clearly recognized by the tenacity of tobacco smoking for most users, and has prompted extensive psychopharmacological studies in animals. In parallel, the interaction of nicotine with the many subtypes of its eponymous receptor has been the focus of molecular and cellular investigations. More recently, a convergence of these approaches has been stimulated by the generation of transgenic animals, which facilitates analysis of the impact of molecular changes on behaviour. Nicotine, like other addictive drugs including psychomotor stimulants, promotes dopamine release in the nucleus accumbens. This transmitter system has been a major focus of both neurochemical and behavioural investigations, although recently the pre-eminence of this system in nicotine dependence has been challenged. Complexities in the brain circuitry (including the subdivisions of the nucleus accumbens) and differences between behavioural models help to rationalise the current controversy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661626     DOI: 10.1016/j.coph.2004.12.002

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  91 in total

Review 1.  Nicotinic modulation of neuronal networks: from receptors to cognition.

Authors:  Huibert D Mansvelder; Karlijn I van Aerde; Jonathan J Couey; Arjen B Brussaard
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

Review 2.  Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.

Authors:  Mark G LeSage; Daniel E Keyler; Paul R Pentel
Journal:  AAPS J       Date:  2006-02-24       Impact factor: 4.009

3.  Sex differences in nicotine levels following repeated intravenous injection in rats are attenuated by gonadectomy.

Authors:  Steven B Harrod; Rosemarie M Booze; Charles F Mactutus
Journal:  Pharmacol Biochem Behav       Date:  2006-12-20       Impact factor: 3.533

4.  Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.

Authors:  Xiu Liu; Anthony R Caggiula; Susan K Yee; Hiroko Nobuta; Alan F Sved; Robert N Pechnick; Russell E Poland
Journal:  Neuropsychopharmacology       Date:  2006-06-21       Impact factor: 7.853

5.  The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.

Authors:  Myung N Kim; Emily M Jutkiewicz; Minjia Zhang; Margaret E Gnegy
Journal:  Neuropharmacology       Date:  2010-10-28       Impact factor: 5.250

6.  Chronic nicotine alters nicotinic receptor-induced presynaptic Ca2+ responses in isolated nerve terminals.

Authors:  John J Dougherty; Jianlin Wu; Tejal K Mehta; Brett Brown; Robert A Nichols
Journal:  Neurochem Res       Date:  2007-12-20       Impact factor: 3.996

7.  Gates and filters: unveiling the physiological roles of nicotinic acetylcholine receptors in dopaminergic transmission.

Authors:  S Wonnacott
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

8.  The endogenous cannabinoid system modulates nicotine reward and dependence.

Authors:  Lisa L Merritt; B R Martin; C Walters; A H Lichtman; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2008-05-01       Impact factor: 4.030

9.  Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.

Authors:  Mark G LeSage; David Shelley; Jason T Ross; F Ivy Carroll; William A Corrigall
Journal:  Pharmacol Biochem Behav       Date:  2008-09-09       Impact factor: 3.533

10.  Mecamylamine, dihydro-beta-erythroidine, and dextromethorphan block conditioned responding evoked by the conditional stimulus effects of nicotine.

Authors:  Amanda M Struthers; Jamie L Wilkinson; Linda P Dwoskin; Peter A Crooks; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2009-09-22       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.